Effects of Cyclo-His-Pro-enriched yeast hydrolysate on blood glucose levels and lipid metabolism in obese diabetic ob/ob mice

키워드

참고문헌 (42)

1. Almdal T, "The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up", Arch Intern Med, 164, pp.1422~1426 (2004)
2. Wild S, "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030", Diabetes Care, 27, pp.2568~2569 (2004)
3. Goldfrank L, "The pernicious panacea: herbal medicine", Hosp Physician, 18, pp.64~69 (1982)
4. Sabu MC, "Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes", J Ethnopharmacol, 83, pp.109~116 (2002)
5. Pari L, "Antihyperglycaemic activity of Musa sapientum flowers: effect on lipid peroxidation in alloxan diabetic rats", Phytother Res, 14, pp.136~138 (2000)
6. Tiwari AK, "Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects", Curr Sci, 83, pp.30~38 (2002)
7. Jung EY, "Glucose tolerance and antioxidant activity of spent brewer’s yeast hydrolysate with a high content of Cyclo-His-Pro (CHP)", J Food Sci, 76, pp.C272~C278 (2011)
8. Hilton CW, "Food contains the bioactive peptide, cyclo(His-Pro)", J Clin Endocrinol Metab, 75, pp.375~378 (1992)
9. Hwang IK, "Effects of cyclo (his-pro) plus zinc on glucose metabolism in genetically diabetic obese mice", Diabetes Obes Metab, 5, pp.317~324 (2003)
10. Song MK, "Anti-hyperglycemic activity of zinc plus cyclo (his-pro) in genetically diabetic Goto-Kakizaki and aged rats", Exp Biol Med (Maywood), 228, pp.1338~1345 (2003)
11. Song MK, "Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control", Metabolism, 54, pp.1480~1489 (2005)
12. Morley JE, "Histidyl-proline diketopiperazine decreases food intake in rats", Brain Res, 210, pp.475~478 (1981)
13. ) in eating disorders, "Neuropeptides", 1989, 185~189
14. Song MK, "Body weight reduction in rats by oral treatment with zinc plus cyclo-(His-Pro)", Br J Pharmacol, 158, pp.442~450 (2009)
15. Jung EY, "Appetite suppressive effects of yeast hydrolysate on nitric oxide synthase (NOS) expression and vasoactive intestinal peptide (VIP) immunoreactivity in hypothalamus", Phytother Res, 22, pp.1417~1422 (2008)
16. Jung EY, "Acute and subacute toxicity of yeast hydrolysate from Saccharomyces cerevisiae", Food Chem Toxicol, 48, pp.1677~1681 (2010)
17. Kim KM, "Yeast hydrolysate reduces body fat of dietary obese rats", Phytother Res, 18, pp.950~953 (2004)
18. Michael B, "Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practices", Toxicol Pathol, 35, pp.742~750 (2007)
19. Peters JM, "Organ weights and water levels of the rat following reduced food intake", J Nutr, 90, pp.354~360 (1966)
20. Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
21. Barham D, "An improved colour reagent for the determination of blood glucose by the oxidase system", Analyst, 97, pp.142~145 (1972)
22. Han GC, "Compound K enhances insulin secretion with beneficial metabolic effects in db", db mice, 2007, pp.55, 10641~10648
23. Kim MJ, "Dissimilarity in Fos and Jun immunoreactivity in hypothalamic regions between obese and lean Zucker rats", Biosci Biotechnol Biochem, 69, pp.1982~1984 (2005)
24. Arner P., "Human fat cell lipolysis: biochemistry, regulation and clinical role", Best Pract Res Clin Endocrinol Metab, 19, pp.471~482 (2005)
25. Galic S, "Adipose tissue as an endocrine organ", Mol Cell Endocrinol, 316, pp.129~139 (2010)
26. Lafontan M, "Lipolysis and lipid mobilization in human adipose tissue", Prog Lipid Res, 48, pp.275~297 (2009)
27. Lin HZ, "Metformin reverses fatty liver disease in obese, leptin-deficient mice", Nat Med, 6, pp.998~1003 (2000)
28. DeFronzo RA., "Pharmacologic therapy for type 2 diabetes mellitus", Ann Intern Med, 131, pp.281~303 (1999)
29. Marles RJ, "Economic and Medicinal Plant Research. Vol. 6", pp.149~188 (1994), Academic Press
30. Lee J, "Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice", J Ethnopharmacol, 115, pp.263~270 (2008)
31. den Boer M, "Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models", Arterioscler Thromb Vasc Biol, 24, pp.644~649 (2004)
32. Arsenault BJ, "Lipid parameters for measuring risk of cardiovascular disease", Nat Rev Cardiol, 8, pp.197~206 (2011)
33. Nofer JR, "HDL and arteriosclerosis: beyond reverse cholesterol transport", Atherosclerosis, 161, pp.1~16 (2002)
34. Reaven GM., "Insulin resistance in noninsulin-dependent diabetes mellitus. Does it exist and can it be measured?", Am J Med, 74, pp.3~17 (1983)
35. Genuth SM, "Insulin resistance in genetically obese, hyperglycemic mice", Endocrinology, 88, pp.1230~1238 (1971)
36. Friedman JE, "Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4", J Clin Invest, 89, pp.701~705 (1992)
37. Klein R, "Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy", Arch Intern Med, 154, pp.2169~2178 (1994)
38. Liu QZ, "Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses", Diabetologia, 36, pp.428~432 (1993)
39. Abraira C, "Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes", Diabetes Care, 18, pp.1113~1123 (1995)
40. Ohkubo Y, "Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study", Diabetes Res Clin Pract, 28, pp.103~117 (1995)
41. Song MK, "Synergistic antidiabetic activities of zinc, cyclo (his-pro), and arachidonic acid", Metabolism, 50, pp.53~59 (2001)
42. Rosenthal MJ, "Effects of arachidonic acid and cyclo (his-pro) on zinc transport across small intestine and muscle tissues", Life Sci, 70, pp.337~348 (2001)

관련 논문AI추천